FDA Regulatory Basics
Drug Safety and PV
Drugs and Biologics
Medical Devices
Reg/Promotion
100

Three Administrative Actions available to the FDA for enforcement of regulations.

What are: 1) Debarment; 2) Warning Letters; 3) Inspectional Observations (Form 483); 4) Suspension or withdrawal of drug approvals

100

There are two primary sources of safety data used for safety signal detection. One of the major disadvantages of this source is that it is estimated to capture less than 10% of actual adverse events to drugs/biologics.

What is Postmarket Safety Reporting

100

The cost for bringing a new drug to market is probably in this range

What is 1 - 2 billion dollars

100

A type of marketing application for a Class II medical device that can be demonstrated to have substantial equivalence to a currently marketed Class II device

What is a 510(k) Marketing Applications

100

Four common violations that may result in warning or untitled letters

•Omitting or minimizing risk information

•Making unsubstantiated claims, including superiority claims

•Overstating efficacy

•Omitting material facts

•Promoting unapproved uses

•Broadening indications

200

The branch of government responsible for the FDA

What is the Executive Branch

200

A plan developed as a component of a REMS intended to inform healthcare professionals (not patients) about product risks.

What is a Communication Plan

200

Preclinical testing is conducted in this test population

What is in Laboratory and Animal studies

200

A type of marketing application for a Class III medical device that would usually include clinical trial data

What is a Premarket Approval (PMA) Marketing Application

200

Promotional marketing must be restricted to information contained in this document or content that is consistent with this document based on guidance

What is the package insert

300

The only governmental agency that can bring criminal charges

What is the Department of Justice

300

Homogeneity of the patient population is one of the limitations of this source of safety data

Clinical trial experience

300

This phase of clinical trials is usually conducted in healthy volunteers, but may be conducted in patients with the disease understudy in some situations

What is Phase 1

300

This type of FDA exemption permits the human clinical testing of an investigational device to collect safety and effectiveness data

What is an Investigational Device Exemption (IDE)

300

This is the type of ad that a company may use that discusses research being conducted in a certain therapeutic area, but does not mention a proprietary or established name of a product

What is an Institutional Ad

400

The FD&C Act was enacted in 1938 as a result of manufacture of this product without safety testing

What is Sulfanilamide Elixir

400

Postmarketing 15-day expedited alert reports are required for these types of adverse events

What are serious and unexpected events

400

Preclinical investigations should follow these quality regulations and requirements

What are Good Laboratory Practices

400

This type of FDA exemption is available for orphan devices and exempts the requirement to demonstrate device effectiveness.

What is a Humanitarian Device Exemption (HDE)

400

This type of promotional advertising is not allow for drugs with a 'black box warning'

What is a Reminder Ad

500

These Amendments were enacted as a result of the thalidomide tragedy and for the first time required both safety and efficacy testing prior to market approval

What are the Kefauver-Harris Drug Amendments

500

This is one of the more common reasons that an adverse event would be considered Serious

Inpatient hospitalization or prolongation of hospitalization

500

This type of application requires filling with the FDA within 30 days prior to starting clinical trials

What is an Investigational New Drug Application

500

For a combination product this describes the component that makes the greatest contribution to the overall intended therapeutic effect and establishes the FDA reviewing center

What is the Primary Mode of Action (PMOA)

500

Promotional materials must be submitted to the FDA at time of first use except for products approved under this mechanism

What is Accelerated Approval